HCAT compared with TLSI: revenue, margins and what each company keeps, and the suppliers and customers both name

HCATHealth Catalyst, Inc.

Mkt capRevenueRevenue

TLSITriSalus Life Sciences, Inc.

Mkt capRevenueRevenue

Compare

HCATHealth Catalyst, Inc.

TLSITriSalus Life Sciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

HCAT

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−2.67%—

Q2 FY26±23.4%▼−25.11%×1.07

May 12 '26±58.0%▲+7.25%×0.13

Q1 FY26±36.1%▼−26.26%×0.73

TLSI

Reportimpliedrealized× implied

Q2 FY26—▲+15.20%—

May 13 '26—▼−41.45%—

Q1 FY26

= impliedHCAT realized, solidTLSI realized, hatchedOne scale, both sides: full bar = 59%× = |realized| ÷ impliedSource: market data

—

▼−6.39%

—

Jan 12 '26—▲+1.21%—

HCATHealth Catalyst, Inc.

1.46▼−2.34%· post 1.46

Mkt cap$111.2MRevenue$56MQ3 FY26Revenue$311MFY25

TLSITriSalus Life Sciences, Inc.

3.27▼−7.36%· post 3.27

ClosedNov 6 '26

Mkt cap$217.4MRevenue$11MQ2 FY26Revenue$45MFY25

Compare

ClosedNov 6 '26

HCATHealth Catalyst, Inc.

TLSITriSalus Life Sciences, Inc.

1.46▼−2.34%post 1.46

Price

3.27▼−7.36%post 3.27

$111.2M

Mkt cap

$217.4M

Q3 FY26$56M

Revenue

$11MQ2 FY26

FY25$311M

Revenue

$45MFY25

HCAT1.46▼−2.34%vsTLSI3.27▼−7.36%ClosedNov 6 '26